Published in J Exp Med on July 21, 1997
p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). J Exp Med (2001) 1.73
Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling. Mol Cell Biol (2000) 1.68
Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling. Genes Dev (2000) 1.48
Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin: possible role in cell migration. EMBO J (1999) 1.31
Phosphoinositide 3-kinase-dependent membrane recruitment of p62(dok) is essential for its negative effect on mitogen-activated protein (MAP) kinase activation. J Exp Med (2001) 1.19
Retracted Silencing of B cell receptor signals in human naive B cells. J Exp Med (2002) 1.09
What goes up must come down: the emerging spectrum of inhibitory receptors. J Exp Med (1997) 1.03
Inhibition of the motility and growth of B16F10 mouse melanoma cells by dominant negative mutants of Dok-1. Mol Cell Biol (2001) 0.99
The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B. Proc Natl Acad Sci U S A (2000) 0.94
Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem (1977) 72.51
The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell (1992) 30.02
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell (1992) 28.36
Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med (1979) 12.22
Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature (1990) 5.57
Profound block in thymocyte development in mice lacking p56lck. Nature (1992) 5.48
Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature (1995) 4.84
Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science (1992) 4.57
Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways. EMBO J (1994) 4.23
Defective B cell development and function in Btk-deficient mice. Immunity (1995) 4.20
Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature (1991) 3.97
Syk tyrosine kinase required for mouse viability and B-cell development. Nature (1995) 3.87
An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis. Nature (1994) 3.30
Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature (1996) 3.29
Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science (1995) 3.24
Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell (1995) 3.17
Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell (1993) 3.08
Association between GTPase activators for Rho and Ras families. Nature (1992) 2.92
Constitutive activation of Src family kinases in mouse embryos that lack Csk. Cell (1993) 2.75
A target for Src in mitosis. Nature (1994) 2.65
Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Mol Cell Biol (1992) 2.60
Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity (1995) 2.50
Protein-tyrosine kinases regulate the phosphorylation, protein interactions, subcellular distribution, and activity of p21ras GTPase-activating protein. Mol Cell Biol (1991) 2.40
Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem (1996) 2.39
Diacylglycerol-stimulated formation of actin nucleation sites at plasma membranes. Science (1992) 2.31
Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src. Proc Natl Acad Sci U S A (1994) 2.24
Specific and redundant roles of Src and Fyn in organizing the cytoskeleton. Nature (1995) 2.22
Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J Immunol (1984) 2.15
c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120RasGAP following epidermal growth factor stimulation. J Cell Biol (1995) 2.06
Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk. Nature (1993) 2.05
Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. Proc Natl Acad Sci U S A (1994) 1.83
Phosphoinositide-binding peptides derived from the sequences of gelsolin and villin. J Biol Chem (1992) 1.81
Impaired expansion of mouse B cell progenitors lacking Btk. Immunity (1995) 1.79
The B-cell antigen receptor complex: structure and signal transduction. Immunol Today (1994) 1.53
Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors. J Exp Med (1985) 1.51
Csk suppression of Src involves movement of Csk to sites of Src activity. Mol Cell Biol (1994) 1.50
Overexpressed Csk tyrosine kinase is localized in focal adhesions, causes reorganization of alpha v beta 5 integrin, and interferes with HeLa cell spreading. Mol Cell Biol (1995) 1.47
Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides. Mol Cell Biol (1993) 1.45
The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src. Mol Cell Biol (1995) 1.26
Tyrosine phosphorylation of CD45 phosphotyrosine phosphatase by p50csk kinase creates a binding site for p56lck tyrosine kinase and activates the phosphatase. Mol Cell Biol (1994) 1.26
Requirement of the SH3 and SH2 domains for the inhibitory function of tyrosine protein kinase p50csk in T lymphocytes. Mol Cell Biol (1995) 1.14
Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones. J Immunol (1986) 1.13
The B lymphocyte calcium response to anti-Ig is diminished by membrane immunoglobulin cross-linkage to the Fc gamma receptor. J Immunol (1987) 1.13
A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling. Nature (1994) 1.12
The GTPase-activating protein of Ras suppresses platelet-derived growth factor beta receptor signaling by silencing phospholipase C-gamma 1. Mol Cell Biol (1995) 1.10
A protein that is highly related to GTPase-activating protein-associated p62 complexes with phospholipase C gamma. Mol Cell Biol (1994) 1.05
The human p62 cDNA encodes Sam68 and not the RasGAP-associated p62 protein. Cell (1996) 1.03
Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn. Mol Cell Biol (1994) 1.00
Functional analysis of Csk in signal transduction through the B-cell antigen receptor. Mol Cell Biol (1994) 0.91
Csk enhances insulin-stimulated dephosphorylation of focal adhesion proteins. Mol Cell Biol (1996) 0.88
Crosslinking of the surface immunoglobulin receptor in B lymphocytes induces a redistribution of neurofibromin but not p120-GAP. Oncogene (1994) 0.87
Human type II Fcgamma receptors inhibit B cell activation by interacting with the p21(ras)-dependent pathway. J Biol Chem (1996) 0.84
Evidence for two distinct 60-kilodalton substrates of the SRC tyrosine kinase. J Biol Chem (1994) 0.84
Subclass specificity of Fc gamma receptor-mediated inhibition of mouse B cell activation. J Immunol (1985) 0.84
Negative signaling via FcgammaRIIB1 in B cells blocks phospholipase Cgamma2 tyrosine phosphorylation but not Syk or Lyn activation. J Biol Chem (1996) 0.83
Csk is constitutively associated with a 60-kDa tyrosine-phosphorylated protein in human T cells. J Biol Chem (1996) 0.77
RAG mutations in human B cell-negative SCID. Science (1996) 3.03
Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity (1999) 2.55
Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen. Immunity (2001) 2.44
Regulation of V(D)J recombination activator protein RAG-2 by phosphorylation. Science (1993) 2.20
Tandem SH2 domains of ZAP-70 bind to T cell antigen receptor zeta and CD3 epsilon from activated Jurkat T cells. J Biol Chem (1993) 2.19
Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex. Immunity (2000) 2.13
Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci U S A (1998) 1.95
A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle. Immunity (1996) 1.86
Cell cycle regulation of V(D)J recombination-activating protein RAG-2. Proc Natl Acad Sci U S A (1994) 1.74
BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement. Proc Natl Acad Sci U S A (1997) 1.63
Cyclin A/CDK2 regulates V(D)J recombination by coordinating RAG-2 accumulation and DNA repair. Immunity (1999) 1.62
V(D)J recombination signal recognition: distinct, overlapping DNA-protein contacts in complexes containing RAG1 with and without RAG2. Immunity (1998) 1.61
RAG-2 promotes heptamer occupancy by RAG-1 in the assembly of a V(D)J initiation complex. Mol Cell Biol (1999) 1.59
A V(D)J recombinase-inducible B-cell line: role of transcriptional enhancer elements in directing V(D)J recombination. Mol Cell Biol (1993) 1.54
Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase. Proc Natl Acad Sci U S A (1998) 1.42
The B-cell-specific Src-family kinase Blk is dispensable for B-cell development and activation. Mol Cell Biol (2000) 1.40
A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. Proc Natl Acad Sci U S A (1993) 1.36
Major histocompatibility complex conformational epitopes are peptide specific. J Exp Med (1992) 1.28
V(D)J recombination and the cell cycle. Immunol Today (1995) 1.14
Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein. J Biol Chem (1994) 1.04
Synergistic activity of STAT3 and c-Jun at a specific array of DNA elements in the alpha 2-macroglobulin promoter. J Biol Chem (2001) 1.03
Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries. Blood (2001) 1.03
RAG-1 and RAG-2-dependent assembly of functional complexes with V(D)J recombination substrates in solution. Mol Cell Biol (1997) 0.98
SH2 domains of the protein-tyrosine kinases Blk, Lyn, and Fyn(T) bind distinct sets of phosphoproteins from B lymphocytes. J Biol Chem (1993) 0.98
A cyclin-dependent kinase homologue, p130PITSLRE is a phosphotyrosine-independent SH2 ligand. J Biol Chem (1994) 0.98
TFII-I, a candidate gene for Williams syndrome cognitive profile: parallels between regional expression in mouse brain and human phenotype. Neuroscience (2004) 0.98
An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein interactions in vitro and in vivo. J Biol Chem (1995) 0.97
Antigen-induced T cell death is regulated by CD4 expression. Int Rev Immunol (2001) 0.97
Double-stranded cleavage by cell extracts near recombinational signal sequences of immunoglobulin genes. Nature (1984) 0.94
Soluble, high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: biochemical probes for analysis and modulation of immune responses. Cell Immunol (1999) 0.94
p150TSP, a conserved nuclear phosphoprotein that contains multiple tetratricopeptide repeats and binds specifically to SH2 domains. J Biol Chem (1996) 0.93
Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: implications for autoimmunity. J Exp Med (2001) 0.93
The Pax-5 gene is alternatively spliced during B-cell development. J Biol Chem (1997) 0.91
Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors. J Exp Med (1997) 0.91
Antigen-specific blockade of T cells in vivo using dimeric MHC peptide. J Immunol (2001) 0.89
Human genetics. Becoming B cells. Nature (1993) 0.89
MHC-based diagnostics and therapeutics - clinical applications for disease-linked genes. Immunol Today (1999) 0.87
Abnormal B-cell function in HTLV-I-tax transgenic mice. Oncogene (1995) 0.86
Analysis of the structure of empty and peptide-loaded major histocompatibility complex molecules at the cell surface. J Exp Med (1994) 0.85
Identification of phosphorylation sites for Bruton's tyrosine kinase within the transcriptional regulator BAP/TFII-I. J Biol Chem (2001) 0.85
Rag-1 mutations associated with B-cell-negative scid dissociate the nicking and transesterification steps of V(D)J recombination. Mol Cell Biol (2001) 0.84
Novel cellular microarray assay for profiling T-cell peptide antigen specificities. J Proteome Res (2010) 0.80
Peptide binding to MHC class I is determined by individual pockets in the binding groove. Scand J Immunol (1997) 0.79
Csk associates with the TCR zeta and epsilon chains through its SH2 domain. Ann N Y Acad Sci (1995) 0.77
Csk is constitutively associated with a 60-kDa tyrosine-phosphorylated protein in human T cells. J Biol Chem (1996) 0.77
Somatic evolution of antibody specificity: setting the clock forward. Nat Immunol (2000) 0.75
Mapping of the gene for the tyrosine kinase Itk to a region of conserved synteny between mouse chromosome 11 and human chromosome 5q. Genomics (1994) 0.75
Arber, Smith and Nathans: Nobel Laureates in medicine and physiology, 1978. Johns Hopkins Med J (1978) 0.75
Expression of human recombinant beta 2-microglobulin by Aspergillus nidulans and its activity. Hum Immunol (1996) 0.75
An algorithm for evaluating human cytotoxic T lymphocyte responses to candidate AIDS vaccines. AIDS Res Hum Retroviruses (1999) 0.75
Do antiidiotypic antibodies mimic antigen? Res Immunol (1994) 0.75